← Leaderboards
Todd Joseph Herron
University Of Michigan At Ann Arbor
$3,019,699
Attributed
$4,468,331
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2006–22$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$4,468,331 · 4
By mechanism
R01$2,897,264 · 1
R44$1,302,037 · 1
R43$224,490 · 1
F32$44,540 · 1
Top collaborators
- Lennane Michel Espinoza-Fonseca4 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- James F Gusella$26,805,352
- David Joseph Kennedy$2,014,803
- Peter A Ward$11,493,015
- Devin L Brown$28,775,275
- Friedhelm Hildebrandt$22,945,432
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoDrug DevelopmentDrug DiscoveryValidationCardiac MyocytesIn VitroSafetyCardiacCellsScreeningArrhythmiaPharmaceutical PreparationsCardiotoxicityMonolayerLaboratoriesCollaborationsCalciumInduced Pluripotent Stem CellCost EffectiveLong-Term EffectsNovel TherapeuticsAdultCardiovascular SystemIn Vitro Testing
Grant awards (8)
Hit-to-lead optimization for heart failure drug discovery$724,316
R01 · FY2022 · HL
Hit-to-lead optimization for heart failure drug discovery$724,316
R01 · FY2021 · HL
Hit-to-lead optimization for heart failure drug discovery$724,316
R01 · FY2020 · HL
hiPSC Cardiomyocyte HTS Electrophysiology System for Detecting Drug Induced Fatal Cardiac Arrhythmias$586,897
R44 · FY2020 · ES · contact PI
Hit-to-lead optimization for heart failure drug discovery$724,316
R01 · FY2019 · HL
hiPSC Cardiomyocyte HTS Electrophysiology System for Detecting Drug Induced Fatal Cardiac Arrhythmias$715,140
R44 · FY2019 · ES · contact PI
Functionally Mature Human Stem Cell Derived Cardiac Monolayers for Cardiotoxicity Testing$224,490
R43 · FY2017 · ES · contact PI
Inherited myosin mutations that cause heart disease$44,540
F32 · FY2006 · HL · contact PI